J.P. Bru
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 20
- Pneumonia and Respiratory Infections 11
- Pharmacology 12
- Antibiotics Pharmacokinetics and Efficacy 12
- Co-authors
- J.‐P. Stahl (15 shared papers)R. Gauzit (10 shared papers)Philippe Lesprit (4 shared papers)M. Dupon (1 shared paper)Aurélien Dinh (2 shared papers)B. Issartel (1 shared paper)Damien Bouhour (1 shared paper)Denis Mulleman (1 shared paper)
In The Last Decade
J.P. Bru
44 papers receiving 886 citations
J.P. Bru's Hit Papers
Peers
Comparison fields: 5 of 87
- Applied Microbiology and Biotechnology 140
- Molecular Medicine 109
- Epidemiology 380
- Microbiology 64
- Infectious Diseases 171
Countries citing papers authored by J.P. Bru
This map shows the geographic impact of J.P. Bru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Bru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Bru more than expected).
Fields of papers citing papers by J.P. Bru
This network shows the impact of papers produced by J.P. Bru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Bru. The network helps show where J.P. Bru may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Bru, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial Hit paper breakdown → | 2014 | 315 |
| 2 | [Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions]. | 1985 | 96 |
| 3 | 2015 | 87 | |
| 4 | 2002 | 54 | |
| 5 | 2012 | 53 | |
| 6 | 2012 | 35 | |
| 7 | 1986 | 33 | |
| 8 | 1986 | 28 | |
| 9 | 2021 | 20 | |
| 10 | 2015 | 18 | |
| 11 | 2015 | 16 | |
| 12 | 2020 | 15 | |
| 13 | 2013 | 14 | |
| 14 | 2003 | 13 | |
| 15 | 2012 | 13 | |
| 16 | 2015 | 11 | |
| 17 | 1994 | 11 | |
| 18 | 2004 | 11 | |
| 19 | 2012 | 9 | |
| 20 | 2017 | 7 |
About J.P. Bru
J.P. Bru is a scholar working on Epidemiology, Pharmacology, Molecular Medicine, Infectious Diseases and Critical Care and Intensive Care Medicine, having authored 45 papers that have together received 925 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Pneumonia and Respiratory Infections (11 papers), Antibiotic Resistance in Bacteria (8 papers), Nosocomial Infections in ICU (6 papers), Antibiotic Use and Resistance (5 papers), Salmonella and Campylobacter epidemiology (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Bacterial Infections and Vaccines (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (140 citations), Molecular Medicine (109 citations), Epidemiology (380 citations), Microbiology (64 citations) and Infectious Diseases (171 citations). J.P. Bru has collaborated with scholars based in France, Belgium and Japan. Frequent co-authors include J.‐P. Stahl, R. Gauzit, Philippe Lesprit, M. Dupon, Aurélien Dinh, B. Issartel, Damien Bouhour, Denis Mulleman, Louis Bernard and J. Gaillat. Their work appears in journals such as Clinical Microbiology and Infection, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Antimicrobial Chemotherapy, Médecine et Maladies Infectieuses and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.